1. Huang, Hongxin, Han, Qin, Zheng, Han, Lu, Fengmin, Wang, Jie. 2021. MAP4K4 mediates the SOX6-induced autophagy and reduces the chemosensitivity of cervical cancer. In Cell death & disease, 13, 13. doi:10.1038/s41419-021-04474-1. https://pubmed.ncbi.nlm.nih.gov/34930918/
2. Singh, Sunil Kumar, Kumar, Sandeep, Viswakarma, Navin, Rana, Basabi, Rana, Ajay. 2021. MAP4K4 promotes pancreatic tumorigenesis via phosphorylation and activation of mixed lineage kinase 3. In Oncogene, 40, 6153-6165. doi:10.1038/s41388-021-02007-w. https://pubmed.ncbi.nlm.nih.gov/34511598/
3. Virbasius, Joseph V, Czech, Michael P. 2016. Map4k4 Signaling Nodes in Metabolic and Cardiovascular Diseases. In Trends in endocrinology and metabolism: TEM, 27, 484-492. doi:10.1016/j.tem.2016.04.006. https://pubmed.ncbi.nlm.nih.gov/27160798/
4. Chuang, Huai-Chia, Tan, Tse-Hua. 2017. MAP4K4 and IL-6+ Th17 cells play important roles in non-obese type 2 diabetes. In Journal of biomedical science, 24, 4. doi:10.1186/s12929-016-0307-7. https://pubmed.ncbi.nlm.nih.gov/28061846/
5. Yang, Pingping, Li, Yadong, Hou, Jing, Zeng, Xiaohua, Zhou, Ding'an. 2024. Blockade of a novel MAP4K4-LATS2-SASH1-YAP1 cascade inhibits tumorigenesis and metastasis in luminal breast cancer. In The Journal of biological chemistry, 300, 107309. doi:10.1016/j.jbc.2024.107309. https://pubmed.ncbi.nlm.nih.gov/38657867/
6. Li, Jin, Sha, Zhao, Zhu, Xiaolan, Yang, Liming, Xiao, Junjie. 2022. Targeting miR-30d reverses pathological cardiac hypertrophy. In EBioMedicine, 81, 104108. doi:10.1016/j.ebiom.2022.104108. https://pubmed.ncbi.nlm.nih.gov/35752105/
7. Zheng, Han, Liu, Mingchen, Shi, Shu, Lu, Fengmin, Wang, Jie. 2024. MAP4K4 and WT1 mediate SOX6-induced cellular senescence by synergistically activating the ATF2-TGFβ2-Smad2/3 signaling pathway in cervical cancer. In Molecular oncology, 18, 1327-1346. doi:10.1002/1878-0261.13613. https://pubmed.ncbi.nlm.nih.gov/38383842/
智鼠故事 
